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Two variants of renal angiomyolipoma (AML)dclassic and epithelioiddhave been described. Although
the epithelioid variant has been reported to demonstrate an aggressive clinical behavior, classic AML is
usually benign. Herein, we report a case of a 42-year-old asymptomatic woman with a lipomatous
variant of renal AML associated with an inferior vena cava thrombus managed with radical nephrectomy
and caval thrombectomy.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.Introduction
Angiomyolipoma (AML) is a benign renal mesenchymal tumor
affecting more than 10 million people worldwide, predominantly
in women aged 40-50 years. It might be sporadic or occurs in asso-
ciation with tuberous sclerosis complex or lymphangioleiomyoma-
tosis (LAM).1 There are 2 variants of AML: classic (triphasic) and
epithelioid.
Although AML is classically benign, the epithelioid variant
can closely mimic renal cell carcinoma radiographically. Epithe-
lioid AML has been reported to exhibit aggressive clinical course
with metastases, recurrences, and high rate of mortality.2-4 Rarely,
AML might invade the major renal vein and/or lymph nodes.
However, involvement of regional lymph nodes is interpreted as
multifocality of growth rather than true metastases or malignant
behavior. Herein, we report a case of lipomatous AML that dem-
onstrates an unusual aggressive behavior with inferior vena cava
(IVC) tumor thrombus.: þ1-516-734-8537.
i).
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The patient is a 42-year-old asymptomatic womanwith no past
medical history referred to us on account of a hyperechoic right
kidney mass and IVC thrombus found on routine abdominal ul-
trasound. Physical examination was unremarkable, and laboratory
values were within normal limits, with hemoglobin of 13.2 g/dL
and creatinine of 0.85 mg/dL. Computed tomographic (CT) scan of
the abdomen conﬁrmed a 3-cm right upper pole renal mass with
central fat attenuation and a 5-cm level II IVC thrombus (extension
into the right renal vein and IVC below the level of the hepatic
veins; Fig. 1A and B). Shortly after imaging diagnosis, she pre-
sented with a 1-week history of pleuritic chest pain and shortness
of breath in the recumbent position. Urgent chest CT angiogram
showed a pulmonary tumor embolus (65 HU) in the right ante-
rior segmental branch of the pulmonary artery, with a corre-
sponding infarct in the medial segment of the right lower lung
lobe. The CT also revealed multiple bilateral lung cysts, suggesting
a diagnosis of LAM.
She underwent a right radical nephrectomy and IVC throm-
bectomy through a modiﬁed Chevron incision. With full mobili-
zation of the right kidney, control of the IVC proximal and distal to
the thrombus, and the contralateral renal vein, a free-ﬂoating
thrombus was easily delivered intact through an anterior
ellipsoid cavotomy. Subsequent to IVC repair, a right radical license.
Figure 1. Axial abdominal computed tomographic scan showing (A) focal mass of fat attenuation in the right kidney and the right renal vein and (B) hyopattenuated tumor
thrombus in the inferior vena cava.
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tions. The patient fared well postoperatively and was discharged
home on postoperative day 4.
Gross specimen examination revealed a 2.5  2.2  2.0 cm
fatty tumor located in the upper pole of the right kidney,
extending into the renal sinus. There was a 6.8  0.9 cm
tumor thrombus protruding through the renal vein, without
involvement of the vein wall (Fig. 2A). Microscopic exami-
nation revealed a tumor composed of adipose tissue
predominantly, scattered thick-walled blood vessels, and
minor smooth muscle cells surrounding abnormal vessels
(Fig. 2B). Immunophenotypic expression includes positive
staining for melanocytic markers (HMB-45) and smooth
muscle markers (SMA, smooth muscle actin). S-100 immu-
nostain showed positive cytoplasmic staining.Figure 2. (A) Gross specimen of the right kidney showing lipomatous tumor thrombus
in the renal vein. (B) Hematoxylin and eosin stain of angiomyolipoma showing 3
components: abnormal thick-walled blood vessel, spindle cells spinning of the vessel
wall, and mature adipose tissue.Discussion
AML is a benign triphasic renal tumor consisting of variable
amount of adipose tissue (-lipo-), smooth muscle cells (-myo-),
and abnormal thick-walled vessels (-angio-). AML most
commonly are sporadic (80%) or are associated with tuberous
sclerosis complex or LAM (20%), with the sporadic variety
occurring with a 4:1 predominance in women. AML more
commonly becomes symptomatic in lesions >4 cm, and include
fever, gastrointestinal upset, ﬂank pain, palpable renal mass,
hematuria, hypertension, anemia, renal failure, and shock from
retroperitoneal hemorrhage.
It is generally recommended that asymptomatic AML might be
monitored annually or semiannually by CT or ultrasound if <4 cm
in its largest diameter. However, persistently symptomatic lesions
<4 cm or lesions 4 cm should be treated with selective arterial
embolization, radiofrequency ablation, or nephron-sparing pro-
cedures.5 However, surgical extirpation might be used in cases of
aggressive, epithelioid, or vessel-invasive AML.
The sequelae of vascular invasion and IVC tumor thrombus in
an aggressive AML can be life threatening, with increased risks of
vessel occlusion and spontaneous retroperitoneal hemorrhage
(Wunderlich syndrome). AML with IVC thrombus, irrespective of
size, must be managed urgently with radical nephrectomy and
caval thrombectomy, as used in this case. Deﬁnitive treatment is
essential to avoid threats of tumor embolism and subsequent
respiratory compromise. Recently, a randomized trial of ever-
olimus vs placebo in patients with >3 cm AML reported 42%
objective response rate (>50% reduction in tumor volume) with
treatment; however, there have been no studies in patients with
locally advanced AML.1
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Rarely, classic renal AML can behave aggressively with tumor
thrombus in the renal vein and IVC. AML with such characteristics
should be managed aggressively with thorough preoperative
radiographic characterization and prompt surgical intervention to
avoid life-threatening complications.
References
1. Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma
associated with tuberous sclerosis complex or sporadic lymphangioleiomyoma-tosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled
trial. Lancet. 2013 Jan 10;81:817e824.
2. Park HK, Zhang S, Wong MKK, Kim HL. Clinical presentation of epithelioid
angiomyolipoma. Int. J. Urol. 2007 Jan;14:21e25.
3. Brimo FF, Robinson BB, Guo CC, et al. Renal epithelioid angiomyolipoma with
atypia: a series of 40 cases with emphasis on clinicopathologic prognostic in-
dicators of malignancy. Audio, Transactions of the IRE Professional Group on.
2010 May 1;34:715-722.
4. Martignoni G, Pea M, Rigaud G, et al. Renal angiomyolipoma with epithelioid
sarcomatous transformation and metastases: demonstration of the same genetic
defects in the primary and metastatic lesions. Am. J. Surg. Pathol. 2000 Jun;24:
889e894.
5. Sooriakumaran PP, Gibbs PP, Coughlin GG, et al. Angiomyolipomata: challenges,
solutions, and future prospects based on over 100 cases treated. BJU Int. 2010 Jan
1;105:101e106.
